X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Non-Small Cell Lung Cancer (NSCLC) Companies

This report lists the top Non-Small Cell Lung Cancer (NSCLC) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Non-Small Cell Lung Cancer (NSCLC) industry.

Non-Small Cell Lung Cancer (NSCLC) Top Companies

  1. F. Hoffmann-La Roche Ltd.

  2. Bristol-Myers Squibb Company

  3. Pfizer Inc.

  4. AstraZeneca

  5. Novartis AG

*Disclaimer: Top companies sorted in no particular order

 Non-Small Cell Lung Cancer (NSCLC) Market Major Players

Non-Small Cell Lung Cancer (NSCLC) Market Concentration

Non-Small Cell Lung Cancer (NSCLC) Market Concentration

Non-Small Cell Lung Cancer (NSCLC) Company List

                            • F. Hoffmann-La Roche Ltd.

                            • AstraZeneca

                            • Bristol-Myers Squibb Company

                            • Merck & Co., Inc.

                            • Novartis AG

                            • Pfizer Inc.

                            • Takeda Pharmaceutical Company Limited

                            • Bayer AG

                            • Eli Lilly and Company

                            • GlaxoSmithKline plc.

                            • Sanofi

                            • Agennix AG


                        Specific to Non-Small Cell Lung Cancer (NSCLC) Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Non-Small Cell Lung Cancer (NSCLC) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)